EW Related Analyst Ratings
-
UBS See More Downside in Edwards Lifesciences (EW), PT Lowered to $64
-
RBC Capital Downgrades Edwards Lifesciences (EW) to Sector Perform
-
Lazard Capital Downgrades Edwards Lifesciences (EW) to Neutral
-
Edwards Lifesciences (EW) Experiences Rubust Heart Valve Sales, Analyst Sees Upside
-
Janney Montgomery Scott Starts Edwards Lifesciences (EW) at Buy
-
JMP Securities Starts Edwards Lifesciences (EW) at Market Perform
-
Stifel Nicolaus Starts Edwards Lifesciences (EW) at Buy
-
UBS Downgrades Edwards Lifesciences (EW) to Sell
-
Citi Downgrades Edwards Lifesciences (EW) to Neutral
-
Canaccord Genuity Defends Edwards Lifesciences (EW)
-
Goldman Sachs Slashes PT on Edwards Lifesciences (EW), Maintains Buy
-
RBC Capital Downgrades Edwards Lifesciences (EW) to Outperform after Warning
-
Jefferies Reiterated Buy on Edwards Lifesciences (EW) after Surveys Show Favorable Results
-
Northland Securities Upgrades Edwards Lifesciences (EW) to Underperform
-
Canaccord Genuity Reiterates a 'Buy' on Edwards Lifesciences (EW); Latest Data Gives Edge to Sapien
-
RBC Capital Downgrades Edwards Lifesciences (EW) to Outperform
-
Goldman Reiterates Buy on Edwards Lifesciences (EW)
-
Canaccord Genuity Reiterates a 'Buy' on Edwards Lifesciences (EW); TAVI Crushes It
-
Credit Suisse Downgrades Edwards Lifesciences (EW) to Neutral
-
UPDATE: UBS Downgrades Edwards Lifesciences (EW) to Neutral; TAVI Outlook Strong, But Already Priced In
-
Canaccord Genuity Reiterates a 'Buy' Edwards Lifesciences (EW); Utilizing TAVI
-
Barclays on Edwards Lifesciences (EW): Q3 Approval Likely, But Staying Sidelined
-
Canaccord Genuity Maintains a 'Buy' on Edwards Lifesciences (EW); Voting in Favor of SAPIEN
-
Jefferies Lifts Target on Edwards Lifesciences (EW) on Positive Panel
-
Canaccord Genuity Raises PT and Estimates on Edwards Lifesciences (EW); Preview of Cohort A Panel
-
Canaccord Genuity Reiterates a' Buy' on Edwards Lifesciences (EW); SOURCE XT Bodes Well for PARTNER II
-
Canaccord Genuity Reiterates a 'Buy' on Edwards Lifesciences (EW); Positive Final NCD
-
Wells Fargo Upgrades Edwards Lifesciences (EW) to Outperform; Final TAVR NCD A Win, More Catalysts To Follow
-
GARP Research Maintains a 'Buy' on Edwards Lifesciences (EW); Hospiteal Interest in TAVI Remains High
-
Canaccord Genuity Suggests Adding To Positions in Edwards Lifesciences (EW); Buy Ahead of Catalysts
-
Barclays on Edwards Lifesciences (EW): Good News, Bad News on TAVR Consensus
-
Canaccord Genuity Maintains a 'Buy' on Edwards Lifesciences (EW); ACC Preview of Cohort A
-
Barclays Maintains an 'Underweight' on Boston Scientific (BSX); Potential Piece in Turnaround Story
-
Goldman Sachs Maintains Top Rating on Edwards Lifesciences (EW), But Trims Numbers
-
Canaccord Genuity Maintains a 'Buy' on Edwards Lifesciences (EW); Adjusting Estimates
-
Credit Suisse Upgrades Edwards Lifesciences (EW) to Outperform
-
Canaccord Genuity Maintains a 'Buy' on Edwards Lifesciences (EW); Q4 Raises Questions; We Think Buying On Weakness Is The Answer
-
Wells Fargo Downgrades Edwards Lifesciences (EW) to Market Perform; Near-Term Uncertainty And Valuation
-
Credit Suisse Downgrades Edwards Lifesciences (EW) to Neutral
-
Canaccord Genuity Reiterates a 'Buy' on Edwards Lifesciences (EW); SAPIEN T-A Data Exceeds Expectations
-
Canaccord Genuity Maintains a 'Buy' on Edwards Lifesciences (EW); Update from STS Tech Con; Expect Solid SAPIEN T/A Data
-
Canaccord Genuity Q4 Med-Tech Preview: Best Ideas (HTWR & EW)
-
Leerink Swann Starts Edwards Lifesciences (EW) at Outperform; Long-Term Growth Story Remains Compelling
-
Edwards Lifesciences (EW) Moves Higher Following Late-Break Abstracts; Jefferies Comments
-
ThinkEquity Starts Edwards Lifesciences (EW) at Buy
-
JPMorgan Upgrades Edwards Lifesciences (EW) to Neutral
-
RBC Capital Upgrades Edwards Lifesciences (EW) to Top Pick, Price Target Offers 36% Upside
-
Barclays Maintains an 'Equalweight' on Edwards Lifesciences (EW); Table Set for Eventful 2012
-
UPDATE - Canaccord Genuity Upgraded Edwards Lifesciences (EW) to Buy; See Positive Risk/Reward
-
Canaccord Genuity Upgrades Edwards Lifesciences (EW) to Buy
Back to EW Stock Lookup
